These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6712202)

  • 1. Pharmacokinetics of cefpiramide (SM-1652) in humans.
    Nakagawa K; Koyama M; Matsui H; Ikeda C; Yano K; Nakatsuru N; Yoshinaga K; Noguchi T
    Antimicrob Agents Chemother; 1984 Feb; 25(2):221-5. PubMed ID: 6712202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefpiramide kinetics and plasma protein binding in cholestasis.
    Demontes-Mainard F; Vinçon G; Labat L; Amouretti M; Necciari J; Kieffer G; Bannwarth B
    Br J Clin Pharmacol; 1994 Mar; 37(3):295-7. PubMed ID: 8198940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefpiramide in healthy volunteers, patients with various degrees of renal dysfunction, and patients on hemodialysis.
    Ohkawa M; Tokunaga S; Sugata T; Shimamura M; Okasho A; Hirano S; Matsui H
    Chemotherapy; 1989; 35(6):416-22. PubMed ID: 2612231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and protein binding of cefpiramide in patients with alcoholic cirrhosis.
    Demotes-Mainard F; Vinçon G; Amouretti M; Dumas F; Necciari J; Kieffer G; Begaud B
    Clin Pharmacol Ther; 1991 Mar; 49(3):263-9. PubMed ID: 2007321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single- and multiple-dose pharmacokinetics of moxalactam in normal subjects.
    Israel KS; Black HR; Brier GL; Wolny JD; DeSante KA
    Antimicrob Agents Chemother; 1982 Jul; 22(1):94-102. PubMed ID: 6214998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cefpiramide in volunteers with normal or impaired renal function.
    Conte JE
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1585-8. PubMed ID: 3435107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental and clinical evaluation of the biliary pharmacokinetic profile of cefpiramide, a new cephalosporin with high hepatic elimination.
    Brogard JM; Jehl F; Blickle JF; Arnaud JP; Monteil H
    Drugs Exp Clin Res; 1988; 14(8):519-27. PubMed ID: 3248507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Concentrations of cefpiramide in bone and joint tissues].
    Higuchi F; Kanazawa C; Inoue H; Inoue A
    Jpn J Antibiot; 1987 Apr; 40(4):743-8. PubMed ID: 3613091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fundamental and clinical study on cefpiramide in obstetrics and gynecology. Obstetrics and Gynecology Study Group for Cefpiramide].
    Takase Z; Fujiwara M; Komoto Y; Seto M; Shirafuji H; Shimizu T; Ishikawa M; Ichinoe K; Kutsuzawa T; Uno Y
    Jpn J Antibiot; 1985 Aug; 38(8):2313-37. PubMed ID: 4079005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High hepatic excretion in humans of cefpiramide, a new cephalosporin.
    Brogard JM; Jehl F; Adloff M; Blickle JF; Monteil H
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1360-4. PubMed ID: 3195998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of cefpiramide in pediatrics].
    Kobayashi Y; Haruta T; Kuroki S; Yamakawa M; Okura K
    Jpn J Antibiot; 1983 Aug; 36(8):2269-74. PubMed ID: 6655846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of cefpiramide and cefoperazone alone and in combination with gentamicin against pseudomonal infections in neutropenic mice.
    Fu KP; Hetzel N; Hung PP; Gregory FJ
    Chemotherapy; 1986; 32(2):166-72. PubMed ID: 3698725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal tubular mechanisms for excretion of cefpiramide (SM-1652) in association with its long-lasting pharmacokinetic properties.
    Matsui H; Okuda T
    J Pharmacobiodyn; 1988 Feb; 11(2):67-73. PubMed ID: 3379566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefotetan (YM09330) in humans.
    Nakagawa K; Koyama M; Tachibana A; Komiya M; Kikuchi Y; Yano K
    Antimicrob Agents Chemother; 1982 Dec; 22(6):935-41. PubMed ID: 6961888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental efficacy and pharmacokinetic properties of cefpiramide, a new cephalosporin.
    Fu KP; Vince T; McCloud S; Gregory FJ; Chiang ST; Hung PP
    Drugs Exp Clin Res; 1985; 11(11):787-91. PubMed ID: 3939215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental and clinical evaluation of cefpiramide in pediatrics].
    Nishimura T; Tabuki K; Hiromatsu K; Takashima T; Takagi M
    Jpn J Antibiot; 1983 Aug; 36(8):2261-8. PubMed ID: 6655845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fundamental and clinical studies of cefpiramide in the field of obstetrics and gynecology].
    Shintani M; Kosakai H; Takayama T; Nakanishi A; Shimamoto I; Ichijo M
    Jpn J Antibiot; 1985 Aug; 38(8):2374-8. PubMed ID: 4079011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The penetration of cefpiramide into the skin].
    Yoshida T; Honma K; Ohura T; Sugano H; Okimoto Y
    Jpn J Antibiot; 1992 Oct; 45(10):1270-4. PubMed ID: 1479678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.
    Barriere SL; Hatheway GJ; Gambertoglio JG; Lin ET; Conte JE
    Antimicrob Agents Chemother; 1982 Jun; 21(6):935-8. PubMed ID: 7114840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of moxalactam in patients with malignant disease.
    Estey EH; Weaver SS; Ho DH; Bodey GP
    Antimicrob Agents Chemother; 1981 Apr; 19(4):639-44. PubMed ID: 6454389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.